Optimizing Empirical Antimicrobial Therapy for Infection due to Gram‐Negative Pathogens in the Intensive Care Unit: Utility of a Combination Antibiogram (original) (raw)

Abstract

objective. To determine whether the use of dual antimicrobial therapy based on the results of a combination antibiotic susceptibility report (antibiogram) increases the likelihood of selecting adequate empirical coverage in critically ill patients with infection due to potentially resistant gram-negative pathogens.

Loading...

Loading Preview

Sorry, preview is currently unavailable. You can download the paper by clicking the button above.

References (32)

  1. Sligl W, Taylor G, Brindley PG. Five years of nosocomial gram-negative bacteremia in a general intensive care unit: epidemiology, antimicrobial susceptibility patterns, and outcomes. Int J Infect Dis 2006;10:320-325.
  2. Gardiner DF, Scholand SJ, Babinchak T. Mortality and gram-negative rod bacteraemia in the intensive care unit. J Hosp Infect 2006;62:453- 457.
  3. Fridkin SK. Increasing prevalence of antimicrobial resistance in intensive care units. Crit Care Med 2001;29:N64-N68.
  4. Flournoy DJ, Reinert RL, Bell-Dixon C, Gentry CA. Increasing anti- microbial resistance in gram-negative bacilli isolated from patients in intensive care units. Am J Infect Control 2000;28:244-250.
  5. Kollef MH, Sherman G, Ward S, Fraser VJ. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among crit- ically ill patients. Chest 1999;115:462-474.
  6. Ibrahim EH, Sherman G, Ward S, Fraser VJ, Kollef MH. The influence of inadequate antimicrobial treatment of bloodstream infections on pa- tient outcomes in the ICU setting. Chest 2000;118:146-155.
  7. Micek ST, Lloyd AE, Ritchie DJ, Reichley RM, Fraser VJ, Kollef MH. Pseudomonas aeruginosa bloodstream infection: importance of appro- priate initial antimicrobial treatment. Antimicrob Agents Chemother 2005; 49:1306-1311.
  8. Lodise TP Jr, Patel N, Kwa A, et al. Predictors of 30-day mortality among patients with Pseudomonas aeruginosa bloodstream infections: impact of delayed appropriate antibiotic selection. Antimicrob Agents Chemother 2007;51:3510-3515.
  9. Fraser A, Paul M, Almanasreh N, et al; TREAT Study Group. Benefit of appropriate empirical antibiotic treatment: thirty-day mortality and du- ration of hospital stay. Am J Med 2006;119:970-976.
  10. Kang C, Kim A, Kim H, et al. Pseudomonas aeruginosa bacteremia: risk factors for mortality and influence of delayed receipt of effective anti- microbial therapy on clinical outcome. Clin Infect Dis 2003;37:745-751.
  11. National nosocomial infections surveillance (NNIS) systems report, data summary from January 1992-June 2001. Am J Infect Control 2001;29:404- 421.
  12. Jones RN. Global epidemiology of antimicrobial resistance among com- munity-acquired and nosocomial pathogens: a five-year summary from the SENTRY antimicrobial surveillance program (1997-2001). Semin Respir Crit Care Med 2003;24:121-134.
  13. Wroblewska MM, Rudnicka J, Marchel H, Luczak M. Multidrug-resistant bacteria isolated from patients hospitalised in intensive care units. Int J Antimicrob Agents 2006;27:285-289.
  14. Kollef MH. Inadequate antimicrobial treatment: an important determi- nant of outcome for hospitalized patients. Clin Infect Dis 2000;31:S131- S138.
  15. Clark NM, Patterson J, Lynch JP 3rd. Antimicrobial resistance among gram-negative organisms in the intensive care unit. Curr Opin Crit Care 2003;9:413-423.
  16. Harbarth S, Nobre V, Pittet D. Does antibiotic selection impact patient outcome? Clin Infect Dis 2007;44:87-93.
  17. Allan JD, Moellering RC Jr. Antimicrobial combinations in the therapy of infections due to gram-negative bacilli. Am J Med 1985;78:65-76.
  18. Mouton JW. Combination therapy as a tool to prevent emergence of bacterial resistance. Infection 1999;27:S24-S28.
  19. Scott RE, Robson HG. Synergistic activity of carbenicillin and gentamicin in experimental Pseudomonas bacteremia in neutropenic rats. Antimicrob Agents Chemother 1976;10:646-651.
  20. Khakoo RA, Kluge RM. Effectiveness of gentamicin and carbenicillin in a rat model against infections with Pseudomonas aeruginosa resistant to gentamicin or gentamicin and carbenicillin. J Antimicrob Chemother 1979; 5:53-59.
  21. Wade JC, Standiford HC, Drusano GL, et al. Potential of imipenem as single-agent empiric antibiotic therapy of febrile neutropenic patients with cancer. Am J Med 1985;78:62-72.
  22. Eron LJ, Harvey L, Hixon DL, Poretz DM. Ciprofloxacin therapy of infections caused by Pseudomonas aeruginosa and other resistant bacteria. Antimicrob Agents Chemother 1985;28:308-310.
  23. Verhagen C, de Pauw BE, Donnelly JP, Williams KJ, de Witte T, Janssen TH. Ceftazidime alone for treating Pseudomonas aeruginosa septicaemia in neutropenic patients. J Infect 1986;13:125-131.
  24. Liang R, Yung R, Chiu E, et al. Ceftazidime versus imipenem-cislatin as initial monotherapy for febrile neutropenic patients. Antimicrob Agents Chemother 1990;34:1336-1341.
  25. Chow JW, Yu VL. Combination antibiotic therapy versus monotherapy for gram-negative bacteraemia: a commentary. Int J Antimicrob Agents 1999;11:7-12.
  26. Safdar N, Handelsman J, Maki DG. Does combination antimicrobial therapy reduce mortality in gram-negative bacteraemia? A meta-analysis. Lancet Infect Dis 2004;4:519-527.
  27. Paul M, Soares-Weiser K, Leibovici L. b-lactam monotherapy versus b- lactam-aminoglycoside combination therapy for fever with neutropenia: systematic review and meta-analysis. BMJ 2003;326:1111.
  28. Paul M, Benuri-Silbiger I, Soares-Weiser K, Leibovici L. b-lactam mono- therapy versus b-lactam-aminoglycoside combination therapy for sepsis in immunocompetent patients: systemic review and meta-analysis of randomized trials. BMJ 2004;328:668.
  29. Leibovici L, Paul M, Poznanski O, et al. Monotherapy versus b-lactam- aminoglycoside combination treatment for gram-negative bacteremia: a prospective, observational study. Antimicrob Agents Chemother 1997;41: 1127-1133.
  30. Mizuta M, Linkin DR, Nachamkin I, et al. Identification of optimal combinations for empirical dual antimicrobial therapy of Pseudomonas aeruginosa infection: potential role of a combination antibiogram. Infect Control Hosp Epidemiol 2006;27:413-415.
  31. Apisarnthanarak A, Mundy LM. Role of combination antibiogram in empirical treatment of infection due to multidrug-resistant Acinetobacter baumannii. Infect Control Hosp Epidemiol 2008;29:678-679.
  32. Paterson DL. Impact of antibiotic resistance in gram-negative bacilli on empirical and definitive antibiotic therapy. Clin Infect Dis 2008;47:S14- S20.